JPJillian K. Perry

Jillian K. Perry

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jillian K. Perry has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Dominic P. Golec

    National Institute of Allergy and Infectious Diseases, National Institutes of Health 5 Cell Signaling and Immunity Section, Laboratory of Immune System Biology, Division of Intramural Research Bethesda, MD

    2 shared publications
  • Pamela L. Schwartzberg

    National Institute of Allergy and Infectious Diseases, National Institutes of Health 5 Cell Signaling and Immunity Section, Laboratory of Immune System Biology, Division of Intramural Research Bethesda, MD

    2 shared publications
  • Alejandro V. Villarino

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, USA

    1 shared publication
  • Anthony C. Cruz

    Lymphocyte Cell Biology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health 5 , Bethesda, MD

    1 shared publication
  • Behdad Afzali

    Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Daniel Chauss

    Immunoregulation Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health 4 , Bethesda, MD

    1 shared publication

Latest Publications

  • Open Access

    An ITK – SLP-76 Y173 Axis Regulates TCR Signal Persistence and Thymic Development

    by Manal Marzouk, Jillian K. Perry, Enas Hallumi, Hirofumi Shibata, Zenia Kaul, Naama Klopstock, Dominic P. Golec, Leslie J. Berg, Pamela L. Schwartzberg, Deborah Yablonski

    The TCR-induced tyrosine kinase cascade results in ITK-mediated phosphorylation of at least two substrates: PLC-γ1 Y783, an essential mediator of TCR signaling, and SLP-76 Y173. We previously provided evidence that SLP-76 Y173 supports proximal TCR and FcεRI signaling; but its role in thymocyte development was never explored. Here we demonstrate that SLP-76 Y173 was required for TCR/CD28-induced degradation of IκB; moreover, both ITK and SLP-76 Y173 were required for persistent TCR-induced phosphorylation of PLC-γ1, ERK and p38. To explore whether SLP-76 Y173 may mediate ITK-dependent events in vivo, we replaced SLP-76 Y173 with phenylalanine in a mouse model. Like ITK-deficient thymocytes, SLP-76 Y173F thymocytes exhibited reduced thymic cellularity, reduced CD4/CD8 ratios, and reduced surface expression of CD5. In ex vivo-stimulated thymocytes, mutation of SLP-76 Y173 or inhibition of ITK reduced the persistence of TCR-induced calcium flux; moreover, TCR-induced phosphorylation of ERK and p38 depended on SLP-76 Y173. Like ITK-deficient thymi, SLP-76 Y173F thymocytes exhibited decreased production of CD4 − iNKT 1 thymocytes, coupled with increased production of innate-like CD4 + and CD8 + SP thymocytes. Our results provide strong evidence that the ITK substrate site, SLP-76 Y173, promotes TCR signal persistence that is required to mediate the thymic developmental effects of ITK. One Sentence Summary: An ITK substrate site, SLP-76 Y173, is a predominant mediator of the signaling and developmental effects of ITK. Key Points: An ITK substrate site, SLP-76 Y173, regulates TCR signal amplitude and persistence Persistent TCR-induced phosphorylation of p38 depends on ITK and SLP-76 Y173 The thymic developmental effects of ITK are predominantly mediated by SLP-76 Y173

  • Open Access

    A PI3Kδ-Foxo1-FasL signaling amplification loop rewires CD4+ T cell signaling and differentiation

    by Dominic P. Golec, Pedro H. Gazzinelli-Guimaraes, Daniel Chauss, Kang Yu, Hiroyuki Nagashima, Anthony C. Cruz, Tom Hill, Sundar Ganesan, Jennifer L. Cannons, Jillian K. Perry, et al.

    While inputs regulating CD4+ T helper (Th) cell differentiation are well defined, the integration of downstream signaling with transcriptional and epigenetic programs that define Th lineage identity remains incompletely resolved. PI3K signaling is a critical regulator of T cell function; activating mutations affecting PI3Kδ result in an immunodeficiency with multiple T cell defects. Using mice expressing activated PI3Kδ, we found aberrant expression of proinflammatory Th1 signature genes under Th2-inducing conditions, both in vivo and in vitro. This dysregulation was driven by a PI3Kδ-IL-2-Foxo1 signaling amplification loop, fueling Foxo1 inactivation, loss of Th2 lineage restriction, and extensive epigenetic reprogramming. Surprisingly, ablation of Fasl, a Foxo1-repressed gene, normalized both Th2 differentiation and TCR signaling. BioID and imaging revealed Fas interactions with TCR signaling components, which were supported by Fas-mediated potentiation of TCR signaling that could occur in the absence of FADD. Our results highlight Fas-FasL signaling as a critical intermediate in phenotypes driven by activated PI3Kδ, thereby linking two key pathways of immune dysregulation.